Skip to content

Study · Observational study · n = 14 · 1996

5 results

Somatotrope responsiveness to Hexarelin, a synthetic hexapeptide, is refractory to the inhibitory effect of glucose in obesity.

Grottoli S, Maccario M, Procopio M, Oleandri SE, Arvat E, Gianotti L, Deghenghi R, Camanni F, Ghigo E

European journal of endocrinology1 Dec 1996Cited by 8 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanObservational studyActivity measurement

    In obese men, the GH response to hexarelin was lower than in normal subjects (p < 0.0002).

    In plain wordsObese men had a smaller growth hormone response to hexarelin than normal-weight men.

    Peptide
    Hexarelin
    Outcome
    DecreaseGH response to hexarelin, obese vs normal subjects
    Study

    n = 14

    Comparator
    Normal subjects
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    2 micrograms/kg · intravenous · single doseAs given in this study (human).

    Measurements

    GH peak
    20 micrograms/l
    obese
    GH peak
    62.6 micrograms/l
    normal subjects

    Source sentences

    Summary
    Hexarelin induced a clear GH rise in OB (peak: 20.0 +/- 2.9 micrograms/l; AUC: 1193.0 +/- 213.7 micrograms.l-1.120 min-1) but this response was clearly lower (p < 0.0002) than that observed in NS (62.6 +/- 7.3 micrograms/l, 4587.5 +/- 614.9 micrograms.l-1.120 min-1).
    2 context sentences
    Summary · context
    To further investigate this point, in eight male obese (OB) patients (27-49 years old; body mass index = 39.5 +/- 1.7 kg/m2) we studied the effect of oral glucose load (100 g) on the GH response to Hexarelin (HEX, 2 micrograms/kg iv), a synthetic hexapeptide belonging to the GH-releasing peptide fam…
    Summary · context
    As a control group, six male age-matched normal subjects (NS) were studied (26-35 years old; body mass index = 22.3 +/- 1.5 kg/m2).
  2. 02HumanObservational studyActivity measurement

    In obese patients and in normal subjects, hexarelin released more GH than GHRH.

    In plain wordsIn obese and normal-weight men, hexarelin released more growth hormone than GHRH did.

    Peptide
    Hexarelin
    Outcome
    IncreaseGH response to hexarelin vs GHRH
    Study

    n = 14

    Comparator
    GHRH
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    2 micrograms/kg · intravenous · single doseAs given in this study (human).

    Source sentences

    Summary
    In OB patients as well as in normal subjects HEX releases more GH than GHRH.
    2 context sentences
    Summary · context
    To further investigate this point, in eight male obese (OB) patients (27-49 years old; body mass index = 39.5 +/- 1.7 kg/m2) we studied the effect of oral glucose load (100 g) on the GH response to Hexarelin (HEX, 2 micrograms/kg iv), a synthetic hexapeptide belonging to the GH-releasing peptide fam…
    Summary · context
    As a control group, six male age-matched normal subjects (NS) were studied (26-35 years old; body mass index = 22.3 +/- 1.5 kg/m2).
  3. 03HumanObservational studyActivity measurement

    In obese men, hexarelin induced a clear GH rise.

    In plain wordsIn obese men, hexarelin caused a clear rise in growth hormone.

    Peptide
    Hexarelin
    Outcome
    IncreaseGH response to hexarelin in obese patients
    Study

    n = 8

    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    2 micrograms/kg · intravenous · single doseAs given in this study (human).

    Measurements

    GH peak
    20 micrograms/l
    obese patients

    Source sentences

    Summary
    Hexarelin induced a clear GH rise in OB (peak: 20.0 +/- 2.9 micrograms/l; AUC: 1193.0 +/- 213.7 micrograms.l-1.120 min-1)
    2 context sentences
    Summary · context
    To further investigate this point, in eight male obese (OB) patients (27-49 years old; body mass index = 39.5 +/- 1.7 kg/m2) we studied the effect of oral glucose load (100 g) on the GH response to Hexarelin (HEX, 2 micrograms/kg iv), a synthetic hexapeptide belonging to the GH-releasing peptide fam…
    Summary · context
    As a control group, six male age-matched normal subjects (NS) were studied (26-35 years old; body mass index = 22.3 +/- 1.5 kg/m2).

Studies that did not test the peptide alone2

In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Hexarelin.

  1. 04HumanNot a test of Hexarelin aloneObservational studyActivity measurement

    In obese patients, an oral glucose load failed to modify the GH response to hexarelin.

    In plain wordsIn obese men, drinking glucose did not change the growth hormone response to hexarelin.

    Peptide
    Hexarelin
    Outcome
    No significant changeEffect of oral glucose on the GH response to hexarelin in obese patients
    Study

    n = 8

    Comparator
    Hexarelin without glucose
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones

    Measurements

    GH peak
    19.4 micrograms/l
    hexarelin after glucose, obese

    Source sentences

    Summary
    but failed to modify it in OB (19.4 +/- 2.7 micrograms/l, 934.5 +/- 151.3 micrograms.l-1.
    2 context sentences
    Summary · context
    To further investigate this point, in eight male obese (OB) patients (27-49 years old; body mass index = 39.5 +/- 1.7 kg/m2) we studied the effect of oral glucose load (100 g) on the GH response to Hexarelin (HEX, 2 micrograms/kg iv), a synthetic hexapeptide belonging to the GH-releasing peptide fam…
    Summary · context
    As a control group, six male age-matched normal subjects (NS) were studied (26-35 years old; body mass index = 22.3 +/- 1.5 kg/m2).

    In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Hexarelin.

  2. 05HumanNot a test of Hexarelin aloneObservational studyActivity measurement

    In normal subjects, an oral glucose load significantly blunted the GH response to hexarelin (p < 0.05).

    In plain wordsIn normal-weight men, drinking glucose reduced the growth hormone response to hexarelin.

    Peptide
    Hexarelin
    Outcome
    DecreaseEffect of oral glucose on the GH response to hexarelin in normal subjects
    Study

    n = 6

    Comparator
    Hexarelin without glucose
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones

    Measurements

    GH peak
    38.4 micrograms/l
    hexarelin after glucose, normal subjects

    Source sentences

    Summary
    In NS, glucose significantly blunted the GH response to HEX (38.4 +/- 7.2 micrograms/l, 2236.5 +/- 514.8 micrograms.l-1.120 min-1, p < 0.05)
    2 context sentences
    Summary · context
    To further investigate this point, in eight male obese (OB) patients (27-49 years old; body mass index = 39.5 +/- 1.7 kg/m2) we studied the effect of oral glucose load (100 g) on the GH response to Hexarelin (HEX, 2 micrograms/kg iv), a synthetic hexapeptide belonging to the GH-releasing peptide fam…
    Summary · context
    As a control group, six male age-matched normal subjects (NS) were studied (26-35 years old; body mass index = 22.3 +/- 1.5 kg/m2).

    In this study, Hexarelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Hexarelin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.